• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双特异性酪氨酸(Y)磷酸化调节激酶1A介导的淀粉样前体蛋白磷酸化:唐氏综合征与阿尔茨海默病之间功能联系的证据。

Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer's disease.

作者信息

Ryoo Soo-Ryoon, Cho Hyun-Jeong, Lee Hye-Won, Jeong Hey Kyeong, Radnaabazar Chinzorig, Kim Yeun-Soo, Kim Min-Jeong, Son Mi-Young, Seo Hyemyung, Chung Sul-Hee, Song Woo-Joo

机构信息

Graduate Program in Neuroscience, Institute for Brain Science and Technology, Inje University, Busan, South Korea.

出版信息

J Neurochem. 2008 Mar;104(5):1333-44. doi: 10.1111/j.1471-4159.2007.05075.x. Epub 2007 Nov 14.

DOI:10.1111/j.1471-4159.2007.05075.x
PMID:18005339
Abstract

Most individuals with Down Syndrome (DS) show an early-onset of Alzheimer's disease (AD), which potentially results from the presence of an extra copy of a segment of chromosome 21. Located on chromosome 21 are the genes that encode beta-amyloid (Abeta) precursor protein (APP ), a key protein involved in the pathogenesis of AD, and dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A (DYRK1A ), a proline-directed protein kinase that plays a critical role in neurodevelopment. Here, we describe a potential mechanism for the regulation of AD pathology in DS brains by DYRK1A-mediated phosphorylation of APP. We show that APP is phosphorylated at Thr668 by DYRK1A in vitro and in mammalian cells. The amounts of phospho-APP and Abeta are increased in the brains of transgenic mice that over-express the human DYRK1A protein. Furthermore, we show that the amounts of phospho-APP as well as those of APP and DYRK1A are elevated in human DS brains. Taken together, these results reveal a potential regulatory link between APP and DYRK1A in DS brains, and suggest that the over-expression of DYRK1A in DS may play a role in accelerating AD pathogenesis through phosphorylation of APP.

摘要

大多数唐氏综合征(DS)患者会过早患上阿尔茨海默病(AD),这可能是由于21号染色体上一段片段的额外拷贝所致。位于21号染色体上的基因编码β-淀粉样蛋白(Aβ)前体蛋白(APP),这是一种参与AD发病机制的关键蛋白,以及双特异性酪氨酸(Y)磷酸化调节激酶1A(DYRK1A),一种在神经发育中起关键作用的脯氨酸定向蛋白激酶。在这里,我们描述了一种由DYRK1A介导的APP磷酸化调节DS大脑中AD病理的潜在机制。我们表明,在体外和哺乳动物细胞中,APP在Thr668位点被DYRK1A磷酸化。在过度表达人类DYRK1A蛋白的转基因小鼠大脑中,磷酸化APP和Aβ的量增加。此外,我们表明在人类DS大脑中,磷酸化APP以及APP和DYRK1A的量都有所升高。综上所述,这些结果揭示了DS大脑中APP和DYRK1A之间潜在的调节联系,并表明DS中DYRK1A的过度表达可能通过APP的磷酸化在加速AD发病机制中发挥作用。

相似文献

1
Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer's disease.双特异性酪氨酸(Y)磷酸化调节激酶1A介导的淀粉样前体蛋白磷酸化:唐氏综合征与阿尔茨海默病之间功能联系的证据。
J Neurochem. 2008 Mar;104(5):1333-44. doi: 10.1111/j.1471-4159.2007.05075.x. Epub 2007 Nov 14.
2
Dyrk1A-mediated phosphorylation of Presenilin 1: a functional link between Down syndrome and Alzheimer's disease.Dyrk1A 介导的早老素 1 磷酸化:唐氏综合征与阿尔茨海默病之间的功能联系。
J Neurochem. 2010 Nov;115(3):574-84. doi: 10.1111/j.1471-4159.2010.06769.x. Epub 2010 Aug 19.
3
The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between beta-amyloid production and tau phosphorylation in Alzheimer disease.DYRK1A基因位于21号染色体唐氏综合征关键区域,在阿尔茨海默病中连接β-淀粉样蛋白生成与tau蛋白磷酸化过程。
Hum Mol Genet. 2007 Jan 1;16(1):15-23. doi: 10.1093/hmg/ddl437. Epub 2006 Nov 29.
4
Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models.组成型Dyrk1A在阿尔茨海默病、唐氏综合征、皮克病及相关转基因模型中异常表达。
Neurobiol Dis. 2005 Nov;20(2):392-400. doi: 10.1016/j.nbd.2005.03.020.
5
Dyrk1A overexpression in immortalized hippocampal cells produces the neuropathological features of Down syndrome.永生海马细胞中Dyrk1A的过表达产生唐氏综合征的神经病理学特征。
Mol Cell Neurosci. 2007 Oct;36(2):270-9. doi: 10.1016/j.mcn.2007.07.007. Epub 2007 Jul 24.
6
Neprilysin Is Suppressed by Dual-Specificity Tyrosine-Phosphorylation Regulated Kinase 1A (DYRK1A) in Down-Syndrome-Derived Fibroblasts.在唐氏综合征来源的成纤维细胞中,中性内肽酶被双特异性酪氨酸磷酸化调节激酶1A(DYRK1A)抑制。
Biol Pharm Bull. 2017;40(3):327-333. doi: 10.1248/bpb.b16-00825.
7
Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.唐氏综合征小鼠模型中 Dyrk1A 基因剂量的正常化可挽救几种阿尔茨海默病表型。
Neurobiol Dis. 2017 Oct;106:76-88. doi: 10.1016/j.nbd.2017.06.010. Epub 2017 Jun 21.
8
[Elucidating Pathogenic Mechanisms of Early-onset Alzheimer's Disease in Down Syndrome Patients].[阐明唐氏综合征患者早发性阿尔茨海默病的致病机制]
Yakugaku Zasshi. 2017;137(7):801-805. doi: 10.1248/yakushi.16-00236-2.
9
A novel DYRK1A (dual specificity tyrosine phosphorylation-regulated kinase 1A) inhibitor for the treatment of Alzheimer's disease: effect on Tau and amyloid pathologies in vitro.一种用于治疗阿尔茨海默病的新型DYRK1A(双重特异性酪氨酸磷酸化调节激酶1A)抑制剂:体外对Tau蛋白和淀粉样病变的影响
J Neurochem. 2015 May;133(3):440-51. doi: 10.1111/jnc.13018. Epub 2015 Jan 26.
10
Amino-terminal modification and tyrosine phosphorylation of [corrected] carboxy-terminal fragments of the amyloid precursor protein in Alzheimer's disease and Down's syndrome brain.阿尔茨海默病和唐氏综合征大脑中淀粉样前体蛋白羧基末端片段的氨基末端修饰和酪氨酸磷酸化[校正后]
Neurobiol Dis. 2001 Feb;8(1):173-80. doi: 10.1006/nbdi.2000.0357.

引用本文的文献

1
Computer-aided discovery of triazolothiadiazoles as DYRK1A-targeted neuroprotective agents.计算机辅助发现作为靶向双特异性酪氨酸磷酸化调节激酶1A的神经保护剂的三唑并噻二唑类化合物。
RSC Med Chem. 2025 Jul 14. doi: 10.1039/d5md00289c.
2
[I]IPPI for Tau Imaging: Binding Studies in Postmortem Human Alzheimer's Disease Hippocampus-Subiculum and Evaluation of Drug Effects.[I]用于tau成像的IPPI:对死后人类阿尔茨海默病海马-下托的结合研究及药物效果评估。
Synapse. 2025 Jul;79(4):e70024. doi: 10.1002/syn.70024.
3
Prospective on Alkaloids-based sustainable methods to treat fungal pathogens: a comprehensive review.
基于生物碱的真菌病原体可持续治疗方法的前瞻性研究:全面综述
Arch Microbiol. 2025 Jun 21;207(8):183. doi: 10.1007/s00203-025-04381-5.
4
Disease-specific neuropathological alterations of the locus coeruleus in Alzheimer's disease, Down syndrome, and Parkinson's disease.阿尔茨海默病、唐氏综合征和帕金森病中蓝斑核的疾病特异性神经病理改变。
Alzheimers Dement. 2025 Jun;21(6):e70262. doi: 10.1002/alz.70262.
5
Unlocking the Therapeutic Potential of the Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A Inhibitors in Alzheimer's Diseases.揭示双特异性酪氨酸磷酸化调节激酶1A抑制剂在阿尔茨海默病中的治疗潜力
Mol Neurobiol. 2025 Mar 5. doi: 10.1007/s12035-025-04806-8.
6
Calcineurin inhibition may prevent Alzheimer disease in people with Down syndrome.抑制钙调神经磷酸酶可能预防唐氏综合征患者患阿尔茨海默病。
Alzheimers Dement. 2025 Mar;21(3):e70034. doi: 10.1002/alz.70034.
7
Cholinergic System Structure and Function Changes in Individuals with Down Syndrome During the Development of Alzheimer's Disease.唐氏综合征个体在阿尔茨海默病发展过程中胆碱能系统结构与功能的变化
Curr Top Behav Neurosci. 2025;69:49-78. doi: 10.1007/7854_2024_523.
8
Updates in Alzheimer's disease: from basic research to diagnosis and therapies.阿尔茨海默病的最新研究进展:从基础研究到诊断和治疗。
Transl Neurodegener. 2024 Sep 4;13(1):45. doi: 10.1186/s40035-024-00432-x.
9
Analysis of microisolated frontal cortex excitatory layer III and V pyramidal neurons reveals a neurodegenerative phenotype in individuals with Down syndrome.分析微分离额皮质兴奋性第 III 和第 V 层的锥体神经元,揭示唐氏综合征个体存在神经退行性表型。
Acta Neuropathol. 2024 Aug 6;148(1):16. doi: 10.1007/s00401-024-02768-0.
10
Discovery of a novel DYRK1A inhibitor with neuroprotective activity by virtual screening and in vitro biological evaluation.通过虚拟筛选和体外生物学评价发现一种具有神经保护活性的新型DYRK1A抑制剂。
Mol Divers. 2025 Feb;29(1):337-350. doi: 10.1007/s11030-024-10856-2. Epub 2024 Jun 4.